Mighty Capital
VC Fund
San Francisco, United States
Mighty Capital is an early-stage venture capital firm that capitalizes on the growing importance of product management in business success. Founded by SC Moatti, a former Facebook mobile tech expert, and Jennifer Vancini, a seasoned professional with over 20 years in tech investments and M&A, the firm taps into Moatti's Products That Countnetwork of over 500,000 product managers and CPOs to gain insights into startups and corporate needs. The real “Why now?” is Covid, which has reshaped corporate power structures, accelerating the shift towards digital products and services, thereby elevating the role of product managers. As a result, Fortune 1000 companies with CPOs have increased 10x in 3 years and are outperforming their peers. Mighty Capital’s focus on this product management revolution has led to high returns and minimized risk. Notable investments include Amplitude, Groq, and Canela. Founders and institutional investors praise the firm for its exceptional value, rapid execution, and ability to spot trends early. Learn more at Mighty.Capital.
- Total investments:
- 62
- Last investment:
- Lead investor:
- 19%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Mighty Capital invests in
Stages Mighty Capital invests in
Countries Mighty Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Allan Kramer
|
|||
Chino Wong
|
|||
Jayme Smaldone
|
|||
Jennifer Vancini
|
|||
Mary Curtis
|
|||
| See all 9 contacts → | |||
Investment Focus
Industry
- Software 15 (24%)
- Artificial Intelligence 14 (23%)
- Health Care 9 (15%)
- SaaS 7 (11%)
- Enterprise Software 7 (11%)
Stage
- Funding Round 18 (29%)
- Seed 10 (16%)
- Series A 8 (13%)
- Venture - Series Unknown 8 (13%)
- Series B 6 (10%)
Country
- United States 37 (60%)
- Canada 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Allan Kramer
Investment Partner
|
Investment Partner | Total investments: 0 | Find email | |
|
Chino Wong
Product Executive-in-Residence
|
Product Executive-in-Residence | Total investments: 0 | Find email | |
|
Jayme Smaldone
CEO
|
CEO | Total investments: 0 | Find email | |
|
Jennifer Vancini
General Partner
|
General Partner | Total investments: 2 | Find email | |
|
Mary Curtis
Partner
|
Partner | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Optimly AI
|
Optimly is the brand trust registry for AI — a verified index of 60,000+ brands that AI agents read from when answering buyer-intent questions. As ChatGPT, Claude, Gemini, and Perplexity become the new intermediaries between brands and buyers, Optimly maintains the structured data layer AI reads from, plus the verification platform brand owners useto correct what AI says about them.The company is building the trust infrastructure for agentic commerce — making brands findable by the right agents, in the right conversations, at the right moments. | $800K / Pre-Seed / Jul 08, 2026 | |
Devplan
|
Devplan is an AI-powered workspace for product development teams, transforming ideas into execution-ready plans by integrating with tools like GitHub, Linear, Jira, and company docs. | $2.5M / Seed / Jun 18, 2026 | |
Angle Health
|
Angle Health provides a technology-enabled health insurance platform to simplify employer-sponsored healthcare benefits. The company's service offers fully configurable group health plans that employers can tailor and deploy quickly through its “Benefit Builder” and “Quote-to-Card” tools, often eliminating the need for individual member-levelunderwriting. It integrates medical, pharmacy, demographic, claims, and population-health data with AI-enabled analytics to help employers, brokers, and care teams anticipate health needs and design plans accordingly.Angle Health’s plans typically include telemedicine, digital behavioral health, chronic-disease management, and access to a national network of doctors and providers—services that are often bundled into standard coverage. | $134M / Series B / Dec 03, 2025 | |
NLPatent
|
NLPatent is a leading AI-based natural language patent search platform used by many Am Law 100 Firms and several Fortune 500 companies. The platform, built from a proprietary fine-tuned Large Language Model, allows users to describe inventions in full sentences, and generates results that are conceptually relevant to the query. NLPatent not onlygenerates results very quickly (seconds vs. hours), but it consistently outperforms human experts. It's an excellent resource for quickly evaluating patentability and conducting more in-depth freedom-to-operate and invalidity searches, often uncovering critical references missed by traditional approaches. NLPatent also offers "AI +Human" outsourcing services through their partnership with Arizona-based search firm, Global Patent Solutions, which can be ordered directly through the NLPatent app. This unique offering combines the expertise of professionally trained searchers with the speed and accuracy of the AI platform, which each analyst is trained to use as part of every search. | $3M / Seed / Nov 11, 2025 | |
Moonshot AI
|
Moonshot AI is a No-code solution that optimizes e-commerce stores automatically. The platform utilizes the power of generative AI to enable brands to constantly iterate on CRO experiments, without requiring design, analysis, or developer resources. | $10M / Seed / Oct 21, 2025 | |
Pensero AI
|
Pensero uses AI to track engineering performance in real time—so managers don’t have to. We turn work data into daily feedback, helping teams stay aligned, accountable, and focused without constant check-ins or outdated reviews. | $6M / Seed / Aug 05, 2025 | |
SportsVisio
|
SportsVisio is a Boston‑based startup (founded in 2021) that offers an AI‑powered, mobile‑first sports analytics platform using computer vision to generate real-time player statistics and automated highlights from games recording on any camera or device. | $3.2M / Seed / Jun 18, 2025 | |
HuLoop Automation, Inc.
|
According to Gartner, the market for hyperautomation reached almost $600B in 2022, and it is expected to continue to experience double digit growth. Companies are turning to hyperautomation solutions to support their business transformation initiatives as they seek to find new, simpler ways of doing business. They are looking for solutions thatwork across disparate technology platforms, data sources, documents, and organizational silos.HuLoop Automation has built a first of its kind unified hyperautomation platform that’s designed to efficiently deliver on the business transformation outcomes that companies seek. HuLoop helps clients to manage profitable revenue growth, drive cost savings, and achieve productivity gains by automating mundane, repetitive activities, freeing up valuable human capacity to focus on more strategically important things such as delighting customers. This AI-powered, no-code platform is extremely easy to learn and use, even for non-technical businesspeople, and it can be live in 90 days. | $6M / Series A / Dec 23, 2024 | |
Groq
|
Groq is a technology company that designs and provides specialized artificial intelligence compute solutions focused on accelerating AI inference workloads using its custom-built Language Processing Unit (LPU) hardware and associated software stack. The company’s core products include purpose-designed silicon and cloud-accessible platforms thatsupport real-time execution of large language models and other AI tasks with low latency and high throughput, enabling developers and enterprises to integrate AI services into production environments efficiently. Groq also delivers cloud-based services that allow customers to access inference capabilities via APIs compatible with popular development tools, supporting seamless integration into existing AI workflows. Its engineering efforts emphasise deterministic performance and streamlined deployment, targeting use cases where speed and cost predictability are critical. Groq engages with partners and customers across sectors that require rapid AI inferencing, and the company’s technology has attracted significant strategic interest and investment within the broader AI infrastructure ecosystem. | $640M / Series D / Aug 05, 2024 | |
HealthBird
|
HealthBird operates in the health insurance and InsurTech industry. It uses AI technology to match users with suitable insurance plans and simplify enrollment. The platform focuses on digital insurance comparison, onboarding, and management services. | Series A / Aug 01, 2024 | |
| See all 62 investments → | |||
Co-Investors
Alumni Ventures
8 deals together
Portfolia
8 deals together
Fusion Fund
4 deals together
TSVC
4 deals together
Alpha Edison
3 deals together
Angeles Investors
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mighty Capital invest in?
Mighty Capital invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Funding Round and Seed stage. Most of the 62 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mighty Capital?
Public channels for Mighty Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mighty Capital?
The team at Mighty Capital includes Allan Kramer (Investment Partner), Chino Wong (Product Executive-in-Residence) and Jayme Smaldone (CEO), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
